PLSI - Phoenix Life Sciences International Limited

Other OTC - Other OTC Delayed Price. Currency in USD
8.00
+4.49 (+127.92%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.51
Open3.80
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.55 - 7.00
52 Week Range3.50 - 48.25
Volume700
Avg. Volume377
Market Cap260.677M
Beta (3Y Monthly)10.57
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswirelast month

    Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License

    DENVER, CO and Port Vila, Vanuatu, June 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, the “Company”), an adaptive healthcare solutions company, today announced that it has signed a binding Memorandum of Understanding (MOU) between the Company and the Ministry of Health on behalf of the Government of Vanuatu, located in the South Pacific. The MOU includes an exclusive 25-year diabetes management program, the creation of a national healthcare network, medical cannabis licensing and approval for Phoenix Life to export globally, both medical products for the targeted treatment of diabetes and generic medical cannabis products from the Republic of Vanuatu.

  • GlobeNewswire2 months ago

    Phoenix Life Sciences International Announces Presentation at MjMicro Cap Conference in Preparation to Uplist to the OTCQB Market

    DENVER, CO, May 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that it will be presenting at the MjMicro Cap Conference on June 25, 2019 at the Westin Grand Central in New York, New York in conjunction with the recently announced share offering and international expansion. Phoenix Life recently announced that the Company had completed filing its 2017 and 2018 financial audits and is now current with respect to public reporting compliance with the SEC and the OTC Markets. Now, having reached fully reporting status, the Company intends to apply for uplisting to the OTCQB market in the near future.

  • GlobeNewswire2 months ago

    Phoenix Life Sciences International Announces Maturine Carlot-Tary as Director of Health and Nutrition

    DENVER, CO, May 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that Ms. Maturine Carlot-Tary has joined the Company as Director of Health and Nutrition. Ms. Maturine Carlot-Tary possesses a strong background in health science with a diploma in Dietetics and Public Health Nutrition from the Fiji School of Medicine and Bachelor of Arts double major in Economics and Human Biosciences from the University of New England. While serving as the Director of Health Planning and Administration for the Ministry of Health in Vanuatu, she gained valuable experience in supervising the following sections: Finance, Human Resources, Health Research & Ethics, WHO open Learning, Vanuatu Centre for Nursing Education, Health Planning, Health Projects, Donor Coordination, Health Information Systems, Central Medical Stores and Pharmacy.

  • GlobeNewswire3 months ago

    Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference

    DENVER, CO, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that it will be executing a $40 million capital raise and presenting at the TABOR Family Office Conference in Sea Island, Georgia. The offering terms of Phoenix Life’s capital raise include a $40 million raise with a minimum subscription of 2,000 shares, or $25,000. In total, the Company is offering 3.2 million shares of the Company’s common stock at a purchase price of $12.50 per share to accredited investors, including qualified family offices and institutional investors.

  • GlobeNewswire3 months ago

    Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018

    DENVER, CO, April 26, 2019 -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, the “Company”), an international adaptive healthcare.

  • GlobeNewswire3 months ago

    Phoenix Life Sciences International Announces John Taleo as Company's Global Head of Security

    DENVER, CO, April 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that John Taleo has been appointed as the Company’s Global Head of Security. In advance of his retirement in February 2018, Taleo served as Acting Commissioner of the Vanuatu Police Service and dedicated 40 years of his career to the force’s service. Prior to that role, he held several positions with the Maritime Security in the Pacific in New Zealand with his most prominent position being Deputy Commissioner of Police.

  • GlobeNewswire3 months ago

    Phoenix Life Sciences International Announces Giving Pledge Commitment and Launch of The Global Health Initiative with Kylie OBrien Ph.D.

    DENVER, CO, April 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced the launch of The Global Health Initiative (“GHI”, the “Foundation”) and the appointment of Dr. Kylie O’Brien as Chief Executive Officer of the Foundation, commencing the next chapter of the founders’ vision of the Company. The Global Health Initiative is an independent non-profit foundation and public charity that combines significant investment, research partnership and a commitment by the founders of Phoenix Life to The Giving Pledge, investing 50% of their holdings in the Company and their future dividends to philanthropic support for creating change in global health.

  • GlobeNewswire3 months ago

    Phoenix Life Sciences International Appoints Tekon Timothy Tumukon as Company's Head of Biosecurity Services

    DENVER, CO, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced the appointment of Tekon Timothy Tumukon as the Company’s Head of Biosecurity Services. Prior to joining Phoenix Life, Tumukon headed the Republic of Vanuatu’s (“Vanuatu”) Department of Biosecurity as the department’s director and played a key role in developing the country’s biosafety framework.

  • GlobeNewswire4 months ago

    Phoenix Life Sciences International Announces Dr. Santus Wari as Company's National Head of Healthcare in the Republic of Vanuatu

    DENVER, CO, March 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that Dr. Santus Wari has joined the company as Head of National Healthcare for the Republic of Vanuatu. Dr. Santus Wari is the former Acting Director of the Vanuatu Department of Curative & Hospital Services and former Vanuatu Ministry of Health Director General of Health.

  • GlobeNewswire4 months ago

    Phoenix Life Announces Annual Financial Report Filings for 2015 and 2016

    DENVER, CO, March 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, the “Company”), an international adaptive healthcare solutions company, today announced that it has filed its Form 10-K Annual Reports, including audited financial reports, with the Securities and Exchange Commission (“SEC”) for the 2015 and 2016 fiscal years as part of the merger and consolidation completed at the end of 2018. Phoenix Life was created through a consolidation of multiple domestic and international businesses. As final audits are being completed for the 2017 and 2018 fiscal years, corresponding 10-K Annual Reports will likewise be filed, providing prospective and current shareholders with current reporting.

  • GlobeNewswire4 months ago

    Phoenix Life Breaks Ground for Network of Community Clinics and Dispensing Pharmacies for the Republic of Vanuatu

    DENVER, CO, March 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, ”the Company”), an international adaptive healthcare solutions company, today announced that it has broken ground on its first Community Clinic and Dispensing Pharmacy for the treatment of diabetes in the Republic of Vanuatu. The Company held a groundbreaking event at 11:00 a.m. on March 5th in Erakor Village, Vanuatu where the Paramount Chief welcomed Phoenix Life officials, such as Global Head of Security and Transport, Former Police Commissioner John Taleo, Head of National Healthcare, Former Director of Port Vila Central Hospital, the Department of Curative & Hospital Services and Vanuatu’s Ministry of Health, Dr. Santus Wari, and Martin Tindall, Phoenix Life CEO and Founder.

  • GlobeNewswire5 months ago

    Phoenix Life Sciences International Announces Michael Gobel as Finance Advisor

    DENVER, CO, Feb. 27, 2019 -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions.

  • GlobeNewswire5 months ago

    Former Assistant U.S. Attorney Joins Phoenix Life Sciences International as Company’s Vice President of Regulatory Affairs

    DENVER, CO, Feb. 01, 2019 -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions.

  • ACCESSWIRE6 months ago

    Phoenix Life Sciences International Featured in the Cannabis Investor Magazine

    ATLANTA, GA / ACCESSWIRE / January 16, 2019 / CannaInvestor Magazine announced today Phoenix Life Sciences International Limited (OTC PINK: PLSI) (''Phoenix Life''), an international adaptive healthcare ...

  • GlobeNewswire6 months ago

    Phoenix Life Sciences International Announces 2019 International Expansion Strategy

    DENVER, CO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, or the “Company”), an international adaptive healthcare solutions company, today announced its 2019 strategy for continued international expansion to its shareholders. Today, I am happy to share with you the Phoenix Life strategy for expansion in 2019. The first step the company is making to further its mission is the establishment of offices and infrastructure in the Oceania region including Australia and the Republic of Vanuatu.  Further, this will include the recruitment of an expanded team of medical, clinical trial, agricultural and pharmaceutical personnel.

  • GlobeNewswire7 months ago

    Phoenix Life Sciences International Announces Doctor Mohyuddin Mirza as Company's New Botany Specialist

    DENVER, CO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Mohyuddin Mirza has joined the company as the Botany Specialist. Dr. Mohyuddin Mirza has over three decades of experience in the management of greenhouse crops from farm to consumers including Echinacea, Rhodeola, and Cannabis and has made a significant economical impact on the botanical products industries in Alberta, Canada. “As Phoenix Life Sciences International moves forward with company expansion in the new year, we are proud to recruit the most well-respected specialists in the growing industry, like Mohyuddin Mirza,” said Phoenix Life Sciences International CEO Martin Tindall.

  • GlobeNewswire7 months ago

    Phoenix Life Sciences International Is Now Accepting Bids for Hemp CBD Producers and Manufacturers

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it is now accepting bids from U.S. licensed producers of industrial hemp to supply various products to be used in the formulation of its botanical pharmaceuticals. “As we move forward with our mission of transforming the future of global healthcare, our next step is partnering with a GMP licensed hemp producers in the U.S. that shares our values and mission to push botanical pharmaceuticals forward throughout the world,” said Phoenix Life CEO Martin Tindall. Phoenix Life is seeking a Good Manufacturing Practice (GMP) licensed industrial hemp partner for both U.S. and foreign markets to commence in January 2019.

  • GlobeNewswire7 months ago

    Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has released an online version of its Investor Relations deck with an accompanying video presentation on its website and at http://phxlife.net/PLSI-Deck. During the presentation video, Phoenix Life CEO Martin Tindall walks prospective investors through the company’s background, overall mission, business model, future plans and information on how to invest in Phoenix Life’s goal of transforming the future of global healthcare. “We are excited to release our Investor Relations deck and video presentation on our company website to provide investors in the public markets with a clear understanding of the business of Phoenix Life, our mission and our objectives,” said Phoenix Life Sciences International CEO Martin Tindall.

  • GlobeNewswire8 months ago

    Phoenix Life Sciences International Announces Angus Stewart as Company’s New Agriculture and Horticulture Senior Advisor

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Angus Stewart has joined the company as the Agriculture and Horticulture Senior Advisor. Angus Stewart has over two decades of experience specializing in horticulture and is currently an Agricultural and Horticultural Scientist and Consultant Plant Breeder of approximately 100 commercially released plant cultivars. Additionally, Stewart has extensive experience with plant breeding techniques of all levels and is well versed in the best practices for the production and extraction of botanical active ingredients like cannabinoids.

  • GlobeNewswire8 months ago

    Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has received an import certificate from the Republic of Vanuatu’s Minister of Health to bring its cannabis diabetes drug Phoenix Metabolic into the country for clinical trials. “With this certificate, we look forward to playing a pivotal role in decreasing the size of the global diabetes epidemic,” said Phoenix Life Sciences International CEO Martin Tindall. Phoenix Life can now import its cannabis-based diabetes drug into Vanuatu and the company hopes to soon announce the launch of clinical trials for its first 1,000 patients.

  • GlobeNewswire8 months ago

    Phoenix Life Sciences International Announces Significant Retirement of Convertible Debt and Elimination of Outstanding Preferred Shares

    Phoenix Life Sciences International Limited (“Phoenix Life”) (PLSI), an international adaptive healthcare solutions company, today announced that it has retired additional convertible debt, positioning the company with no more outstanding preferred shares or debt that is subject to conversion. As a part of the implementation of its fiscal policy aimed at bringing shareholders value and forwarding the company's mission of creating a global platform for plant-based pharmaceuticals, including bringing medical cannabis products into the mainstream of healthcare, the company has retired its outstanding Series C debt and canceled its Series A and B. “To operate under the umbrella company Phoenix Life Sciences International, we executed the consolidation of various entities and focused on eliminating as much expensive debt as possible,” said Martin Tindall, Chief Executive Officer of Phoenix Life Sciences International.

  • GlobeNewswire8 months ago

    Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has completed the last stages the consolidation of businesses and received approval from the Financial Industry Regulatory Authority (“FINRA”) of the corporate action completing its name change and change of stock symbol. “After five years of planning and hard work, we could not be more excited to have completed this consolidation to build a world changing organization,” said Martin Tindall, CEO of Phoenix Life Sciences International. “This marks the end of what has been a long transitional period for our company and the beginning of a new chapter of opportunity for Phoenix Life.